New arrangements for migalastat (Galafold) – patient fact sheet
About this resource
Publication date:
Publication type:
Fact sheet
Audience:
General public
Language:
English
Australian Government Department of Health, Disability and Ageing
New arrangements for migalastat (Galafold®) for treatment of Fabry Disease
This fact sheet is for current and future patients with Fabry disease explaining how a treatment for this condition, migalastat (Galafold®), will be transitioning from the Life Saving Drugs Program to the PBS. It provides further clarity on future access arrangements via the PBS.